Mario L Marques-Piubelli

28PUBLICATIONS
165CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumoursMedical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Camilla O Hoff, Simon Heeke, Yoshitsugu Mitani

|Jul 08, 2025
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic Implications.

Juliana Mota Siqueira, Yoshitsugu Mitani, Mario L Marques-Piubelli

|Jul 03, 2024
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management.

Luis Malpica, Mario L Marques-Piubelli, Brady E Beltran

|Mar 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides.

Mario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma

|Jan 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.

Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose

|Jan 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.

Woo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan

Pageof 5

Frequent Collaborators

7 joint publications

Francisco Vega

6 joint publications

Carlos A Torres-Cabala

6 joint publications

Roberto N Miranda

4 joint publications

Priyadharsini Nagarajan